- call +1-201-465-4211
- email sales@mrinsights.biz
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
Scope of the Report:
It is costly to discover and develop new drugs/medicines due to expensive research processes, Costs associated with clinical trials, resource-intensive approval procedures and costs associated
With manufacturing (if the trials are successful).
An additional point is that European R&D costs are higher than in other world regions due to the fragmented European patent system. The implications of a fragmented patent system in Europe include high uncertainty, quality drop and prohibitive costs, which are at least four times higher than in the US, China and South Korea thus constituting a financial burden on especially small biopharmaceutical enterprises in Europe (van Pottelsberghe 2009).
The worldwide market for Biopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Biopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Market Segment by Applications, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biopharmaceuticals, with price, sales, revenue and global market share of Biopharmaceuticals in 2017 and 2018.
Chapter 3, the Biopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Biopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Biopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Biopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal Antibodies
1.2.2 Interferon
1.2.3 Colony-Stimulating Factor
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Growth Hormones
1.2.8 Others
1.3 Market Analysis by Applications
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Biopharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Biopharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 AbbVie
2.3.1 Business Overview
2.3.2 Biopharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofi-Aventis
2.4.1 Business Overview
2.4.2 Biopharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi-Aventis Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Biopharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Biopharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.2 Biopharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novo Nordisk Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Eli Lilly
2.8.1 Business Overview
2.8.2 Biopharmaceuticals Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Novartis
2.9.1 Business Overview
2.9.2 Biopharmaceuticals Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Merck
2.10.1 Business Overview
2.10.2 Biopharmaceuticals Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biopharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Biopharmaceuticals Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Biopharmaceuticals Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Biopharmaceuticals Manufacturer Market Share in 2018
3.3.2 Top 6 Biopharmaceuticals Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Biopharmaceuticals Market Analysis by Regions
4.1 Global Biopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Biopharmaceuticals Sales and Market Share by Regions (2014-2019)
4.1.2 Global Biopharmaceuticals Revenue and Market Share by Regions (2014-2019)
4.2 North America Biopharmaceuticals Sales and Growth Rate (2014-2019)
4.3 Europe Biopharmaceuticals Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Biopharmaceuticals Sales and Growth Rate (2014-2019)
4.5 South America Biopharmaceuticals Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Biopharmaceuticals Sales and Growth Rate (2014-2019)
5 North America Biopharmaceuticals by Country
5.1 North America Biopharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Biopharmaceuticals Sales and Market Share by Country (2014-2019)
5.1.2 North America Biopharmaceuticals Revenue and Market Share by Country (2014-2019)
5.2 United States Biopharmaceuticals Sales and Growth Rate (2014-2019)
5.3 Canada Biopharmaceuticals Sales and Growth Rate (2014-2019)
5.4 Mexico Biopharmaceuticals Sales and Growth Rate (2014-2019)
6 Europe Biopharmaceuticals by Country
6.1 Europe Biopharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Biopharmaceuticals Sales and Market Share by Country (2014-2019)
6.1.2 Europe Biopharmaceuticals Revenue and Market Share by Country (2014-2019)
6.2 Germany Biopharmaceuticals Sales and Growth Rate (2014-2019)
6.3 UK Biopharmaceuticals Sales and Growth Rate (2014-2019)
6.4 France Biopharmaceuticals Sales and Growth Rate (2014-2019)
6.5 Russia Biopharmaceuticals Sales and Growth Rate (2014-2019)
6.6 Italy Biopharmaceuticals Sales and Growth Rate (2014-2019)
7 Asia-Pacific Biopharmaceuticals by Country
7.1 Asia-Pacific Biopharmaceuticals Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Biopharmaceuticals Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Biopharmaceuticals Revenue and Market Share by Country (2014-2019)
7.2 China Biopharmaceuticals Sales and Growth Rate (2014-2019)
7.3 Japan Biopharmaceuticals Sales and Growth Rate (2014-2019)
7.4 Korea Biopharmaceuticals Sales and Growth Rate (2014-2019)
7.5 India Biopharmaceuticals Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Biopharmaceuticals Sales and Growth Rate (2014-2019)
8 South America Biopharmaceuticals by Country
8.1 South America Biopharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Biopharmaceuticals Sales and Market Share by Country (2014-2019)
8.1.2 South America Biopharmaceuticals Revenue and Market Share by Country (2014-2019)
8.2 Brazil Biopharmaceuticals Sales and Growth Rate (2014-2019)
8.3 Argentina Biopharmaceuticals Sales and Growth Rate (2014-2019)
8.4 Colombia Biopharmaceuticals Sales and Growth Rate (2014-2019)
9 Middle East and Africa Biopharmaceuticals by Countries
9.1 Middle East and Africa Biopharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Biopharmaceuticals Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Biopharmaceuticals Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Biopharmaceuticals Sales and Growth Rate (2014-2019)
9.3 Turkey Biopharmaceuticals Sales and Growth Rate (2014-2019)
9.4 Egypt Biopharmaceuticals Sales and Growth Rate (2014-2019)
9.5 Nigeria Biopharmaceuticals Sales and Growth Rate (2014-2019)
9.6 South Africa Biopharmaceuticals Sales and Growth Rate (2014-2019)
10 Global Biopharmaceuticals Market Segment by Type
10.1 Global Biopharmaceuticals Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Biopharmaceuticals Sales and Market Share by Type (2014-2019)
10.1.2 Global Biopharmaceuticals Revenue and Market Share by Type (2014-2019)
10.2 Monoclonal Antibodies Sales Growth and Price
10.2.1 Global Monoclonal Antibodies Sales Growth (2014-2019)
10.2.2 Global Monoclonal Antibodies Price (2014-2019)
10.3 Interferon Sales Growth and Price
10.3.1 Global Interferon Sales Growth (2014-2019)
10.3.2 Global Interferon Price (2014-2019)
10.4 Colony-Stimulating Factor Sales Growth and Price
10.4.1 Global Colony-Stimulating Factor Sales Growth (2014-2019)
10.4.2 Global Colony-Stimulating Factor Price (2014-2019)
10.5 Erythropoietin Sales Growth and Price
10.5.1 Global Erythropoietin Sales Growth (2014-2019)
10.5.2 Global Erythropoietin Price (2014-2019)
10.6 Insulin Sales Growth and Price
10.6.1 Global Insulin Sales Growth (2014-2019)
10.6.2 Global Insulin Price (2014-2019)
10.7 Vaccines Sales Growth and Price
10.7.1 Global Vaccines Sales Growth (2014-2019)
10.7.2 Global Vaccines Price (2014-2019)
10.8 Growth Hormones Sales Growth and Price
10.8.1 Global Growth Hormones Sales Growth (2014-2019)
10.8.2 Global Growth Hormones Price (2014-2019)
10.9 Others Sales Growth and Price
10.9.1 Global Others Sales Growth (2014-2019)
10.9.2 Global Others Price (2014-2019)
11 Global Biopharmaceuticals Market Segment by Application
11.1 Global Biopharmaceuticals Sales Market Share by Application (2014-2019)
11.2 Tumor Sales Growth (2014-2019)
11.3 Diabetes Sales Growth (2014-2019)
11.4 Cardiovascular Sales Growth (2014-2019)
11.5 Hemophilia Sales Growth (2014-2019)
11.6 Others Sales Growth (2014-2019)
12 Biopharmaceuticals Market Forecast (2019-2024)
12.1 Global Biopharmaceuticals Sales, Revenue and Growth Rate (2019-2024)
12.2 Biopharmaceuticals Market Forecast by Regions (2019-2024)
12.2.1 North America Biopharmaceuticals Market Forecast (2019-2024)
12.2.2 Europe Biopharmaceuticals Market Forecast (2019-2024)
12.2.3 Asia-Pacific Biopharmaceuticals Market Forecast (2019-2024)
12.2.4 South America Biopharmaceuticals Market Forecast (2019-2024)
12.2.5 Middle East and Africa Biopharmaceuticals Market Forecast (2019-2024)
12.3 Biopharmaceuticals Market Forecast by Type (2019-2024)
12.3.1 Global Biopharmaceuticals Sales Forecast by Type (2019-2024)
12.3.2 Global Biopharmaceuticals Market Share Forecast by Type (2019-2024)
12.4 Biopharmaceuticals Market Forecast by Application (2019-2024)
12.4.1 Global Biopharmaceuticals Sales Forecast by Application (2019-2024)
12.4.2 Global Biopharmaceuticals Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Biopharmaceuticals Picture
Table Product Specifications of Biopharmaceuticals
Figure Global Sales Market Share of Biopharmaceuticals by Types in 2018
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
